Clinical Enrolment Assay to Detect Pre-existing Neutralizing Antibodies to AAV6 With Demonstrated Transgene Expression in Gene Therapy Trials

Time: 9:00 am
day: Day Two


  • Clinical enrollment cut off determination for pre-screening patients supporting AAV6 gene therapy trials
  • Does assay format matter? NAb or TAb approach for clinical trial eligibility criteria
  • Explore AAV6 seroprevalence evaluations